Target Price | $29.50 |
Price | $2.47 |
Potential |
1,094.33%
register free of charge
|
Number of Estimates | 4 |
4 Analysts have issued a price target Protara Therapeutics Inc 2025 .
The average Protara Therapeutics Inc target price is $29.50.
This is
1,094.33%
register free of charge
$50.00
1,924.29%
register free of charge
$20.00
709.72%
register free of charge
|
|
A rating was issued by 4 analysts: 4 Analysts recommend Protara Therapeutics Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Protara Therapeutics Inc stock has an average upside potential 2025 of
1,094.33%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -3.57 | -3.06 |
39.08% | 14.29% | |
P/E | negative |
4 Analysts have issued a Protara Therapeutics Inc forecast for earnings per share. The average Protara Therapeutics Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Protara Therapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.